CDH1 and breast cancer: To verify the universal application of the prepared EMT electrochemical sensor, we analyzed E-cadherin levels in RBE liver cancer, MCF7 breast cancer, SKOV3 ovarian cancer, and PANC1 pancreatic cancer cell lines before and after TGF treatment.